Distinct requirements for CD1d intracellular transport for development of Vα14 iNKT cells

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 1780-1788

  Sillé, Fenna C M ^a,b   Boxem, Mike ^c   Sprengers, Dave ^a,d   Veerapen, Natacha ^e   Besra, Gurdyal ^e   Boes, Marianne ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; ENHANCED YELLOW FLUORESCENT FUSION PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG; PHOTOPROTEIN; YELLOW FLUORESCENT PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EFFECTOR CELL; INTRACELLULAR TRANSPORT; MOLECULE; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; V ALPHA INVARIANT NATURAL KILLER CELL; WILD TYPE; ANIMAL; ANTIGEN PRESENTATION; CYTOLOGY; METABOLISM; NATURAL KILLER T CELL; PROTEIN MOTIF; PROTEIN TRANSPORT; THYMUS;

AMINO ACID MOTIFS; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; LUMINESCENT PROTEINS; MICE; NATURAL KILLER T-CELLS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; THYMUS GLAND;

EID: 68149171494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901354     Document Type: Article

References (46)

1. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. α -galactosylceramide-activated Vα 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97: 8461-8466.
2. Wang, B., Y. B. Geng, and C. R. Wang. 2001. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194: 313-320.
3. Liu, K., J. Idoyaga, A. Charalambous, S. Fujii, A. Bonito, J. Mordoh, R. Wainstok, X. F. Bai, Y. Liu, and R. M. Steinman. 2005. Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. J. Exp. Med. 202: 1507-1516.
4. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
5. De Silva, A. D., J. J. Park, N. Matsuki, A. K. Stanic, R. R. Brutkiewicz, M. E. Medof, and S. Joyce. 2002. Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J. Immunol. 168: 723-733.
6. Rauch, J., J. Gumperz, C. Robinson, M. Skold, C. Roy, D. C. Young, M. Lafleur, D. B. Moody, M. B. Brenner, C. E. Costello, and S. M. Behar. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278: 47508-47515.
7. Kang, S. J., and P. Cresswell. 2002. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 21: 1650-1660.
8. Jayawardena-Wolf, J., K. Benlagha, Y. H. Chiu, R. Mehr, and A. Bendelac. 2001. CD1d endosomal trafficking is independently regulated by an intrinsic CD1-dencoded tyrosine motif and by the invariant chain. Immunity 15: 897-908.
9. Chiu, Y. H., S. H. Park, K. Benlagha, C. Forestier, J. Jayawardena-Wolf, P. B. Savage, L. Teyton, and A. Bendelac. 2002. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3: 55-60.
10. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
11. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
12. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
13. + stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102: 5114-5119.
14. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716.
15. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978.
16. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
17. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
18. + cells. J. Immunol. 164: 2412-2418.
19. Forestier, C., S. H. Park, D. Wei, K. Benlagha, L. Teyton, and A. Bendelac. 2003. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J. Immunol. 171: 4096-4104. (Pubitemid 37238685)
20. Wei, D. G., H. Lee, S. H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202: 239-248.
21. Benlagha, K., D. G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202: 485-492.
22. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169: 2397-2406. (Pubitemid 34920982)
23. McNab, F. W., S. P. Berzins, D. G. Pellicci, K. Kyparissoudis, K. Field, M. J. Smyth, and D. I. Godfrey. 2005. The influence of CD1d in postselection NKT cell maturation and homeostasis. J. Immunol. 175: 3762-3768.
24. Hammond, K. J., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167: 1164-1173.
25. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056.
26. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize selfantigens loaded in different cellular compartments. J. Exp. Med. 189: 103-110.
27. Pellicci, D. G., A. P. Uldrich, K. Kyparissoudis, N. Y. Crowe, A. G. Brooks, K. J. Hammond, S. Sidobre, M. Kronenberg, M. J. Smyth, and D. I. Godfrey. 2003. Intrathymic NKT cell development is blocked by the presence of α-galactosylceramide. Eur. J. Immunol. 33: 1816-1823.
28. Chun, T., M. J. Page, L. Gapin, J. L. Matsuda, H. Xu, H. Nguyen, H. S. Kang, A. K. Stanic, S. Joyce, W. A. Koltun, et al. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 197: 907-918.
29. Exley, M. A., N. J. Bigley, O. Cheng, S. M. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, and S. P. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukocyte Biol. 69: 713-718.
30. Chen, Y. H., B. Wang, T. Chun, L. Zhao, S. Cardell, S. M. Behar, M. B. Brenner, and C. R. Wang. 1999. Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice. J. Immunol. 162: 4560-4566.
31. Park, S. H., J. H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160: 3128-3134.
32. Boes, M., J. Cerny, R. Massol, M. Op den Brouw, T. Kirchhausen, J. Chen, and H. L. Ploegh. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418: 983-988.
33. Schumann, J., M. P. Mycko, P. Dellabona, G. Casorati, and H. R. MacDonald. 2006. Cutting edge: influence of the TCR Vβ domain on the selection of semiinvariant NKT cells by endogenous ligands. J. Immunol. 176: 2064-2068.
34. Dao, T., D. Guo, A. Ploss, A. Stolzer, C. Saylor, T. E. Boursalian, J. S. Im, and D. B. Sant'Angelo. 2004. Development of CD1d-restricted NKT cells in the mouse thymus. Eur. J. Immunol. 34: 3542-3552.
35. + NKT cells in the thymus. J. Immunol. 176: 4059-4065.
36. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762.
37. Bendelac, A., P. Matzinger, R. A. Seder, W. E. Paul, and R. H. Schwartz. 1992. Activation events during thymic selection. J. Exp. Med. 175: 731-742.
38. Prigozy, T. I., O. Naidenko, P. Qasba, D. Elewaut, L. Brossay, A. Khurana, T. Natori, Y. Koezuka, A. Kulkarni, and M. Kronenberg. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664-667.
39. Raftery, M. J., F. Winau, S. H. Kaufmann, U. E. Schaible, and G. Schonrich. 2006. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J. Immunol. 177: 6207-6214.
40. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
41. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V(α)24 natural killer T cells. J. Exp. Med. 195: 637-641.
42. + thymocytes selected by MHC class I molecules. Science 263: 1774-1778.
43. - thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178: 901-908.
44. + thymocytes. J. Exp. Med. 180: 395-399.
45. + cells in the liver of mice. J. Exp. Med. 180: 699-704.
46. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of V α 14i NKT cells. Nat. Immunol. 3: 966-974.